Nayron Medeiros Soares
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nayron Medeiros Soares has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Gabriela Magalhães Pereira
Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Porto Alegre RS, Brazil
11 shared publications - Carlos Roberto Mello Rieder
Universidade Federal de Ciências da Saúde de Porto Alegre, Departamento de Neurologia, Porto Alegre RS, Brazil
7 shared publications - Ana Carolina Leonardi Dutra
Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Porto Alegre RS, Brazil
6 shared publications - Nathalie Ribeiro Artigas
Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Porto Alegre RS, Brazil
6 shared publications Gabriela Magalhães Pereira
Universidade Federal do Rio Grande do Sul Porto Alegre Brazil
4 shared publications- Júlia Schneider Krimberg
University of Toronto, Department of Cell and Systems Biology, Toronto ON, Canada
4 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by Wolters Kluwer Health in Journal of Medical Physics
- Vol. 51 (2) , 277-284
Impact of Grid Size on Dose Calculations for Cranial Tumors
Purpose: The purpose of this study was to evaluate the impact of calculation grid size on dose calculations for multiple cranial tumor types using Monte Carlo (MC) calculation, comparing different grid settings. Methods: This cross-sectional study optimized 110 treatment plans using Elements Cranial and included arteriovenous malformation (AVM), glioblastoma (GBM), meningioma (MGM), brain metastasis (BM), pituitary adenoma (PA), and vestibular schwannoma (VS). Dose coverage at D98%, D95%, and D2%, along with mean dose, were assessed, and other relevant planning and anatomical parameters were analyzed. Results: GBM had the largest gross tumor volume and planning target volume (PTV) volumes, while VS had the smallest volumes and the highest PTV–bone intersection. For MC, grid size variations (1%/1 mm vs. 2%2 mm) did not significantly affect AVM, GBM, or MGM. However, statistically significant dose reductions were observed for BM, PA, and VS. When adjusted for PTV volume and bone intersection, median dose values decreased with the 2%/2 mm grid compared to the 1%/1 mm grid: D98% (25.60 Gy vs. 25.27 Gy, adjusted P = 0.026), D95% (27.05 Gy vs. 26.14 Gy, adjusted P = 0.005), and D2% (30.48 Gy vs. 30.00 Gy, adjusted P < 0.001). Application of the 2%/2 mm grid resulted in increased conformity index (CI) and gradient index (GI) values, with the effect being more pronounced in smaller or anatomically irregular targets, such as VS and PA. Conclusions: Grid size impacted dose calculations for small or irregular targets such as BM, PA, and VS. The 2%/2 mm grid led to significant dose reductions and increased CI and GI values.
- 1 April 2026
- Published by Wolters Kluwer Health in Journal of Medical Physics
- Vol. 51 (2) , 277-284
Open AccessImpact of Grid Size on Dose Calculations for Cranial Tumors
Purpose: The purpose of this study was to evaluate the impact of calculation grid size on dose calculations for multiple cranial tumor types using Monte Carlo (MC) calculation, comparing different grid settings. Methods: This cross-sectional study optimized 110 treatment plans using Elements Cranial and included arteriovenous malformation (AVM), glioblastoma (GBM), meningioma (MGM), brain metastasis (BM), pituitary adenoma (PA), and vestibular schwannoma (VS). Dose coverage at D98%, D95%, and D2%, along with mean dose, were assessed, and other relevant planning and anatomical parameters were analyzed. Results: GBM had the largest gross tumor volume and planning target volume (PTV) volumes, while VS had the smallest volumes and the highest PTV–bone intersection. For MC, grid size variations (1%/1 mm vs. 2%2 mm) did not significantly affect AVM, GBM, or MGM. However, statistically significant dose reductions were observed for BM, PA, and VS. When adjusted for PTV volume and bone intersection, median dose values decreased with the 2%/2 mm grid compared to the 1%/1 mm grid: D98% (25.60 Gy vs. 25.27 Gy, adjusted P = 0.026), D95% (27.05 Gy vs. 26.14 Gy, adjusted P = 0.005), and D2% (30.48 Gy vs. 30.00 Gy, adjusted P < 0.001). Application of the 2%/2 mm grid resulted in increased conformity index (CI) and gradient index (GI) values, with the effect being more pronounced in smaller or anatomically irregular targets, such as VS and PA. Conclusions: Grid size impacted dose calculations for small or irregular targets such as BM, PA, and VS. The 2%/2 mm grid led to significant dose reductions and increased CI and GI values.
- Open Access
- 23 March 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (04) , 001-008
Prevalence and clinical characteristics of impulse control disorder in Southern Brazilian Parkinson's disease patients
Impulse control disorders (ICDs) are potentially serious complications of Parkinson's disease (PD). Treatment, particularly the use of dopamine agonists (DAs), is associated with the development of ICDs and related behaviors. However, susceptibility to these disorders appears to be linked to specific risk factors. To assess the frequency, clinical presentation, and factors associated with the development of ICDs in a population of patients with PD. Patients with PD were screened for ICD-related symptoms using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson''s Disease -Current Short (QUIP-CS) questionnaire. Additionally, they underwent cognitive evaluation and were assessed using the Movement Disorder Society–Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Sociodemographic data and disease progression information were collected. Levodopa equivalent daily dose (LEDD) was calculated for each patient. Of the 90 patients evaluated, 42 (46.6%) exhibited symptoms of ICDs. The most frequent subtype was binge eating (50%), followed by compulsive buying (33.3%) and hypersexuality (21.4%). A significant association was found between DA use and the development of ICDs (p = 0.041). Patients with ICDs using DAs had a higher mean LEDD (p < 0.001) and a higher frequency of motor complications (MDS-UPDRS Part IV, p = 0.028) compared to those not using DAs. In the current study, the use of DAs was the main risk factor associated with the development of impulse control disorders. No other significant associated factors could be identified.
- 23 March 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (04) , 001-008
Open AccessPrevalence and clinical characteristics of impulse control disorder in Southern Brazilian Parkinson's disease patients
Impulse control disorders (ICDs) are potentially serious complications of Parkinson's disease (PD). Treatment, particularly the use of dopamine agonists (DAs), is associated with the development of ICDs and related behaviors. However, susceptibility to these disorders appears to be linked to specific risk factors. To assess the frequency, clinical presentation, and factors associated with the development of ICDs in a population of patients with PD. Patients with PD were screened for ICD-related symptoms using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson''s Disease -Current Short (QUIP-CS) questionnaire. Additionally, they underwent cognitive evaluation and were assessed using the Movement Disorder Society–Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Sociodemographic data and disease progression information were collected. Levodopa equivalent daily dose (LEDD) was calculated for each patient. Of the 90 patients evaluated, 42 (46.6%) exhibited symptoms of ICDs. The most frequent subtype was binge eating (50%), followed by compulsive buying (33.3%) and hypersexuality (21.4%). A significant association was found between DA use and the development of ICDs (p = 0.041). Patients with ICDs using DAs had a higher mean LEDD (p < 0.001) and a higher frequency of motor complications (MDS-UPDRS Part IV, p = 0.028) compared to those not using DAs. In the current study, the use of DAs was the main risk factor associated with the development of impulse control disorders. No other significant associated factors could be identified.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 58, e20250016
Diagnostic reference levels in interventional radiology: a systematic review
Objective: To comprehensively and impartially analyze the scientific evidence available for establishing diagnostic reference levels (DRLs) in interventional radiology. Method: This was a systematic review conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The search focused on studies related to interventional radiology and DRLs in PubMed/Medline and Embase. Studies involving computed tomography-guided procedures, studies with incomplete data, and systematic reviews were excluded. Two independent reviewers evaluated the studies, resolving discrepancies with a third reviewer. Articles were tabulated with information such as title, publication year, procedures, DRL values, and type of equipment used. Results: A total of 475 articles were identified. After duplicates had been excluded and eligibility criteria had been applied, the final sample comprised 30 articles. Most DRL values (73%) were reported at the local level, as defined by International Commission on Radiological Protection criteria, representing typical dose values from a sample within one or a few institutions. A total of 113 procedures were identified, with endovascular aneurysm repair and nephrostomy being the most frequently reported. We identified DRLs at national and regional scales, predominantly within Europe. Influencing factors included technology, operator experience, specific protocols, and optimization strategies. The analysis also identified a lack of longitudinal studies assessing changes over time. The use of dose management software emerged as an effective tool for facilitating data collection and DRL establishment. Conclusion: The lack of standardized procedural terminology hindered direct DRL comparisons. Our findings highlight a predominance of European studies and emphasize the need for broader international efforts to improve DRL implementation.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 58, e20250016
Open AccessDiagnostic reference levels in interventional radiology: a systematic review
Objective: To comprehensively and impartially analyze the scientific evidence available for establishing diagnostic reference levels (DRLs) in interventional radiology. Method: This was a systematic review conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The search focused on studies related to interventional radiology and DRLs in PubMed/Medline and Embase. Studies involving computed tomography-guided procedures, studies with incomplete data, and systematic reviews were excluded. Two independent reviewers evaluated the studies, resolving discrepancies with a third reviewer. Articles were tabulated with information such as title, publication year, procedures, DRL values, and type of equipment used. Results: A total of 475 articles were identified. After duplicates had been excluded and eligibility criteria had been applied, the final sample comprised 30 articles. Most DRL values (73%) were reported at the local level, as defined by International Commission on Radiological Protection criteria, representing typical dose values from a sample within one or a few institutions. A total of 113 procedures were identified, with endovascular aneurysm repair and nephrostomy being the most frequently reported. We identified DRLs at national and regional scales, predominantly within Europe. Influencing factors included technology, operator experience, specific protocols, and optimization strategies. The analysis also identified a lack of longitudinal studies assessing changes over time. The use of dose management software emerged as an effective tool for facilitating data collection and DRL establishment. Conclusion: The lack of standardized procedural terminology hindered direct DRL comparisons. Our findings highlight a predominance of European studies and emphasize the need for broader international efforts to improve DRL implementation.
- Open Access
- 30 September 2024
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 10 (1) , 1-12
A systematic review and meta-analysis of the prevalence of Parkinson’s disease in lower to upper-middle-income countries
Parkinson’s disease (PD) is a common neurodegenerative disease that is a growing public health challenge. Estimates of the burden of PD have focused on data from high-income countries, with lower-income countries poorly described. We reviewed and examined the prevalence of PD reported by studies in low- to upper-middle-income countries. A systematic literature search was performed in the Medline/PubMed, Embase, LILACS, and Web of Science databases. Age group, sex, and geographic region were considered when analyzing the data. Of the 4327 assessed articles, 57 met the inclusion criteria for qualitative review, and 36 were included in the meta-analysis. Heterogeneity measures were high both as a whole and in each geographic region. Data analysis by geographic region showed that reported prevalence differed across regions, ranging from 49 per 100,000 (Sub-Saharan Africa) to 1081 per 100,000 (Latin America and the Caribbean). There was an increasing prevalence of PD with advancing age (per 100,000): 7 in 40–49 years, 158 in 50–59 years, 603 in 60–69 years, 1251 in 70–79 years, and 2181 in over the age of 80. The prevalence of PD in men and women was similar. There was a greater PD prevalence in populations with a higher 5-year GDP per capita and a higher life expectancy. Our findings suggest a higher prevalence of PD in lower and upper-middle-income countries than previously reported. Comparisons between regions are difficult, as the sociocultural differences and lack of methodological standardization hinder understanding key epidemiological data in varied populations.
- 30 September 2024
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 10 (1) , 1-12
Open AccessA systematic review and meta-analysis of the prevalence of Parkinson’s disease in lower to upper-middle-income countries
Parkinson’s disease (PD) is a common neurodegenerative disease that is a growing public health challenge. Estimates of the burden of PD have focused on data from high-income countries, with lower-income countries poorly described. We reviewed and examined the prevalence of PD reported by studies in low- to upper-middle-income countries. A systematic literature search was performed in the Medline/PubMed, Embase, LILACS, and Web of Science databases. Age group, sex, and geographic region were considered when analyzing the data. Of the 4327 assessed articles, 57 met the inclusion criteria for qualitative review, and 36 were included in the meta-analysis. Heterogeneity measures were high both as a whole and in each geographic region. Data analysis by geographic region showed that reported prevalence differed across regions, ranging from 49 per 100,000 (Sub-Saharan Africa) to 1081 per 100,000 (Latin America and the Caribbean). There was an increasing prevalence of PD with advancing age (per 100,000): 7 in 40–49 years, 158 in 50–59 years, 603 in 60–69 years, 1251 in 70–79 years, and 2181 in over the age of 80. The prevalence of PD in men and women was similar. There was a greater PD prevalence in populations with a higher 5-year GDP per capita and a higher life expectancy. Our findings suggest a higher prevalence of PD in lower and upper-middle-income countries than previously reported. Comparisons between regions are difficult, as the sociocultural differences and lack of methodological standardization hinder understanding key epidemiological data in varied populations.
- 27 August 2024
- Published by Springer Nature in Neuroradiology
- Vol. 66 (11) , 1955-1966
Diffusion tensor metrics, motor and non-motor symptoms in de novo Parkinson’s disease
Introduction Parkinson’s disease (PD) is a neurodegenerative disorder characterized by dopaminergic neurons’ degeneration of the substantia nigra, presenting with motor and non-motor symptoms. We hypothesized that altered diffusion metrics are associated with clinical symptoms in de novo PD patients. Methods Fractional Anisotropy (FA) and Mean (MD), Axial (AD), and Radial Diffusivity (RD) were assessed in 55 de novo PD patients (58.62 ± 9.85 years, 37 men) and 55 age-matched healthy controls (59.92 ± 11.25 years, 34 men). Diffusion-weighted images and clinical variables were collected from the Parkinson’s Progression Markers Initiative study. Tract-based spatial statistics were used to identify white matter (WM) changes, and fiber tracts were localized using the JHU-WM tractography atlas. Motor and non-motor symptoms were evaluated in patients. Results We observed higher FA values and lower RD values in patients than controls in various fiber tracts (p-TFCE < 0.05). No significant MD or AD difference was observed between groups. Diffusion metrics of several regions significantly correlated with non-motor (state and trait anxiety and daytime sleepiness) and axial motor symptoms in the de novo PD group. No correlations were observed between diffusion metrics and other clinical symptoms evaluated. Conclusion Our findings suggest microstructural changes in de novo PD fiber tracts; however, limited associations with clinical symptoms reveal the complexity of PD pathology. They may contribute to understanding the neurobiological changes underlying PD and have implications for developing targeted interventions. However, further longitudinal research with larger cohorts and consideration of confounding factors are necessary to elucidate the underlying mechanisms of these diffusion alterations in de novo PD.
- 27 August 2024
- Published by Springer Nature in Neuroradiology
- Vol. 66 (11) , 1955-1966
Diffusion tensor metrics, motor and non-motor symptoms in de novo Parkinson’s disease
Introduction Parkinson’s disease (PD) is a neurodegenerative disorder characterized by dopaminergic neurons’ degeneration of the substantia nigra, presenting with motor and non-motor symptoms. We hypothesized that altered diffusion metrics are associated with clinical symptoms in de novo PD patients. Methods Fractional Anisotropy (FA) and Mean (MD), Axial (AD), and Radial Diffusivity (RD) were assessed in 55 de novo PD patients (58.62 ± 9.85 years, 37 men) and 55 age-matched healthy controls (59.92 ± 11.25 years, 34 men). Diffusion-weighted images and clinical variables were collected from the Parkinson’s Progression Markers Initiative study. Tract-based spatial statistics were used to identify white matter (WM) changes, and fiber tracts were localized using the JHU-WM tractography atlas. Motor and non-motor symptoms were evaluated in patients. Results We observed higher FA values and lower RD values in patients than controls in various fiber tracts (p-TFCE < 0.05). No significant MD or AD difference was observed between groups. Diffusion metrics of several regions significantly correlated with non-motor (state and trait anxiety and daytime sleepiness) and axial motor symptoms in the de novo PD group. No correlations were observed between diffusion metrics and other clinical symptoms evaluated. Conclusion Our findings suggest microstructural changes in de novo PD fiber tracts; however, limited associations with clinical symptoms reveal the complexity of PD pathology. They may contribute to understanding the neurobiological changes underlying PD and have implications for developing targeted interventions. However, further longitudinal research with larger cohorts and consideration of confounding factors are necessary to elucidate the underlying mechanisms of these diffusion alterations in de novo PD.
- Open Access
- 1 July 2024
- Published by Editora RECIMA21 LTDA in RECIMA21 - Revista Científica Multidisciplinar
- Vol. 5 (7) , e575508
AVALIAÇÃO DAS ALTERAÇÕES POSTURAIS NA DOENÇA DE PARKINSON E SUAS RELAÇÕES COM ASPECTOS MOTORES: UM ESTUDO DE COORTE
A Doença de Parkinson (DP) é uma doença crônica degenerativa caracterizada por sintomas motores clássicos. Verifica-se a necessidade de maior esclarecimento sobre as alterações posturais de indivíduos com DP e suas relações com a capacidade motora, visando compreender estas relações para auxiliar na elaboração de condutas fisioterapêuticas adequadas, diminuindo os comprometimentos motores e melhorando a funcionalidade e qualidade de vida (QV) destes pacientes. O objetivo deste estudo foi avaliar as alterações do alinhamento postural dos indivíduos com DP no período de um ano. Método: Estudo de coorte prospectiva com análise quantitativa dos dados. A amostra foi composta por indivíduos de ambos os sexos, com idade superior a 45 anos, que apresentavam diagnóstico de DP realizado por um neurologista e que realizavam acompanhamento no Ambulatório de Neurologia do Hospital de Clínicas de Porto Alegre (HCPA) e aceitaram participar do estudo, assinando o Termo de Consentimento Livre e Esclarecido (TCLE) e respondendo à anamnese e às escalas aplicadas. Resultados: Os indivíduos foram capazes de permanecer em ortostase por, no mínimo, 10 segundos. Foi realizada a avaliação postural por biofotogrametria e os indivíduos foram orientados a retornarem após um ano para reavaliação. Os resultados sugerem que não houve piora significativa nas pontuações dos testes motores aplicados no período de um ano. Conclusão: As articulações analisadas não obtiveram piora significativa de seus padrões posturais ao longo de um ano, pois a grande maioria dos pacientes participantes desta coorte mantiveram-se estáveis quanto à progressão da doença de acordo com o estadiamento de Hoen & Yahr.
- 1 July 2024
- Published by Editora RECIMA21 LTDA in RECIMA21 - Revista Científica Multidisciplinar
- Vol. 5 (7) , e575508
Open AccessAVALIAÇÃO DAS ALTERAÇÕES POSTURAIS NA DOENÇA DE PARKINSON E SUAS RELAÇÕES COM ASPECTOS MOTORES: UM ESTUDO DE COORTE
A Doença de Parkinson (DP) é uma doença crônica degenerativa caracterizada por sintomas motores clássicos. Verifica-se a necessidade de maior esclarecimento sobre as alterações posturais de indivíduos com DP e suas relações com a capacidade motora, visando compreender estas relações para auxiliar na elaboração de condutas fisioterapêuticas adequadas, diminuindo os comprometimentos motores e melhorando a funcionalidade e qualidade de vida (QV) destes pacientes. O objetivo deste estudo foi avaliar as alterações do alinhamento postural dos indivíduos com DP no período de um ano. Método: Estudo de coorte prospectiva com análise quantitativa dos dados. A amostra foi composta por indivíduos de ambos os sexos, com idade superior a 45 anos, que apresentavam diagnóstico de DP realizado por um neurologista e que realizavam acompanhamento no Ambulatório de Neurologia do Hospital de Clínicas de Porto Alegre (HCPA) e aceitaram participar do estudo, assinando o Termo de Consentimento Livre e Esclarecido (TCLE) e respondendo à anamnese e às escalas aplicadas. Resultados: Os indivíduos foram capazes de permanecer em ortostase por, no mínimo, 10 segundos. Foi realizada a avaliação postural por biofotogrametria e os indivíduos foram orientados a retornarem após um ano para reavaliação. Os resultados sugerem que não houve piora significativa nas pontuações dos testes motores aplicados no período de um ano. Conclusão: As articulações analisadas não obtiveram piora significativa de seus padrões posturais ao longo de um ano, pois a grande maioria dos pacientes participantes desta coorte mantiveram-se estáveis quanto à progressão da doença de acordo com o estadiamento de Hoen & Yahr.
- 10 February 2024
- Published by Elsevier in Journal of Medical Imaging and Radiation Sciences
- Vol. 55 (1) , 146-157
Stereotatic radiosurgery for the treatment of motor symptoms in Parkinson's disease: A systematic review
- 10 February 2024
- Published by Elsevier in Journal of Medical Imaging and Radiation Sciences
- Vol. 55 (1) , 146-157
Stereotatic radiosurgery for the treatment of motor symptoms in Parkinson's disease: A systematic review
- 3 January 2024
- Published by Wiley in Psychogeriatrics
- Vol. 24 (2) , 242-248
Influence of loneliness and social isolation before and during the COVID‐19 pandemic on mood, cognition and sleep
Background: Social isolation and loneliness are public health problems and are related to poor physical and mental health in older persons, especially during the COVID‐19 pandemic. We investigated the influences of social isolation and loneliness on mood, cognition and sleep quality in older persons.Methods: This study evaluated 82 older persons, with a median age of 69.16 years (range: 60.00–85.97). The older persons were assessed before and during the period of the COVID‐19 pandemic. Cognition was assessed using the Montreal Cognitive Assessment, symptoms of depression using the Beck Depression Inventory II, symptoms of anxiety using the Beck Anxiety Inventory, quality of sleep by the Pittsburgh Sleep Quality Index, daytime sleepiness by the Epworth Sleepiness Scale, isolation by the Duke Social Support Index and three‐item UCLA Loneliness Scale.Results: Our results revealed that loneliness is related to worsening anxiety symptoms (P = 0.008), and sleep quality (P = 0.011). Isolation is related to worsening sleep quality (P = 0.011). On the other hand, participants who did not isolate themselves during the pandemic felt more anxious (P = 0.021). In addition, older persons who were not isolated (P = 0.035) and had no loneliness (P = 0.007), have higher cognitive performance over time.Conclusion: Loneliness is related to worsening symptoms of anxiety and sleep quality. Our results showed that social isolation is related to worsening sleep quality. On the other hand, high social support during the COVID‐19 pandemic increased anxiety. Furthermore, better cognitive performance is related to non‐isolated and non‐lonely participants.
- 3 January 2024
- Published by Wiley in Psychogeriatrics
- Vol. 24 (2) , 242-248
Influence of loneliness and social isolation before and during the COVID‐19 pandemic on mood, cognition and sleep
Background: Social isolation and loneliness are public health problems and are related to poor physical and mental health in older persons, especially during the COVID‐19 pandemic. We investigated the influences of social isolation and loneliness on mood, cognition and sleep quality in older persons.Methods: This study evaluated 82 older persons, with a median age of 69.16 years (range: 60.00–85.97). The older persons were assessed before and during the period of the COVID‐19 pandemic. Cognition was assessed using the Montreal Cognitive Assessment, symptoms of depression using the Beck Depression Inventory II, symptoms of anxiety using the Beck Anxiety Inventory, quality of sleep by the Pittsburgh Sleep Quality Index, daytime sleepiness by the Epworth Sleepiness Scale, isolation by the Duke Social Support Index and three‐item UCLA Loneliness Scale.Results: Our results revealed that loneliness is related to worsening anxiety symptoms (P = 0.008), and sleep quality (P = 0.011). Isolation is related to worsening sleep quality (P = 0.011). On the other hand, participants who did not isolate themselves during the pandemic felt more anxious (P = 0.021). In addition, older persons who were not isolated (P = 0.035) and had no loneliness (P = 0.007), have higher cognitive performance over time.Conclusion: Loneliness is related to worsening symptoms of anxiety and sleep quality. Our results showed that social isolation is related to worsening sleep quality. On the other hand, high social support during the COVID‐19 pandemic increased anxiety. Furthermore, better cognitive performance is related to non‐isolated and non‐lonely participants.
- Open Access
- 25 April 2023
- Published by Editora Unijui in Revista Contexto & Saúde
- Vol. 23 (47) , e13935
Axial and appendicular postural abnormalities and associations with balance, gait and physical function in individuals with Parkinson's disease
Background: Individuals with Parkinson disease (PD) may have a flexed posture, but only axial postural abnormalities (PAs) are generally investigated. Purpose: The objective was to verify if PAs of the axial and appendicular skeleton observed in PD occur in an interrelated manner to maintain balance and physical function. Methods: A cross-sectional observational study. Sixty-nine individuals with PD were evaluated by computerized photogrammetry. The MDS-UPDRS scale was used to analyze the physical function and the Mini-BESTest to assess balance. To determine the relationship between PAs and clinical aspects, multiple linear regression analysis was performed, setting age and levodopa equivalent dose as covariates. Results: The anterior trunk inclination angles were significantly correlated with the flexion angles of the elbows, hips and knees (p˂0.01). Larger head flexion was correlated with worsening physical function (p=0.013) and gait (p=0.043); greater trunk, hip and knee flexion were correlated with reduced postural instability (p˂0.05), and greater knee flexion was correlated with improvements in gait deficits (p=0.013). Conclusion: Postural abnormalities in the axial and appendicular joints of people with PD appear to occur in an organized and interrelated manner as a body compensation used to improve physical function and reduce balance and gait deficits.
- 25 April 2023
- Published by Editora Unijui in Revista Contexto & Saúde
- Vol. 23 (47) , e13935
Open AccessAxial and appendicular postural abnormalities and associations with balance, gait and physical function in individuals with Parkinson's disease
Background: Individuals with Parkinson disease (PD) may have a flexed posture, but only axial postural abnormalities (PAs) are generally investigated. Purpose: The objective was to verify if PAs of the axial and appendicular skeleton observed in PD occur in an interrelated manner to maintain balance and physical function. Methods: A cross-sectional observational study. Sixty-nine individuals with PD were evaluated by computerized photogrammetry. The MDS-UPDRS scale was used to analyze the physical function and the Mini-BESTest to assess balance. To determine the relationship between PAs and clinical aspects, multiple linear regression analysis was performed, setting age and levodopa equivalent dose as covariates. Results: The anterior trunk inclination angles were significantly correlated with the flexion angles of the elbows, hips and knees (p˂0.01). Larger head flexion was correlated with worsening physical function (p=0.013) and gait (p=0.043); greater trunk, hip and knee flexion were correlated with reduced postural instability (p˂0.05), and greater knee flexion was correlated with improvements in gait deficits (p=0.013). Conclusion: Postural abnormalities in the axial and appendicular joints of people with PD appear to occur in an organized and interrelated manner as a body compensation used to improve physical function and reduce balance and gait deficits.
- Open Access
- 1 January 2023
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 81 (01) , 040-046
Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
Background Levodopa is the most used and effective medication for motor symptoms of Parkinson disease (PD), its long-term use is associated with the appearance of levodopa-induced dyskinesia (LID). Uric acid (UA) is believed to play an important neuroprotective role in PD. Objective To investigate if serum UA levels are related with the presence of LIDs in PD patients. Also, we investigated the associations among UA levels and clinical features of PD. Methods We enrolled 81 PD patients (dyskinesia = 48; no dyskinesia = 33) in the present study. A blood sample was collected to evaluate serum UA levels, clinical evaluation included the following instruments: Montreal Cognitive Assessment (MoCA), Beck Depression Inventory II (BDI-II), MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Hoehn and Yahr (HY), and the sub-item 4.1 of MDS-UPDRS IV (score ≥ 1). Additional relevant clinical information was obtained by a clinical questionnaire. Results Serum UA levels were lower in the dyskinesia group when compared with the no dyskinesia group. The same result was found in the UA levels of both men and women. The multivariate analysis showed lower uric acid levels were significantly associated with having dyskinesia (odds ratio [OR] = 0.424; 95% confidence interval [CI]: 0.221–0.746; p = 0.005). Additional analysis verified that serum UA levels are inversely correlated with depressive symptoms, disease duration, MDS-UPDRS IV and time spent with dyskinesia. A positive correlation was found with age at onset of PD symptoms. Conclusions The present study provides a possible role of serum UA levels in LID present in PD patients.
- 1 January 2023
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 81 (01) , 040-046
Open AccessLow serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
Background Levodopa is the most used and effective medication for motor symptoms of Parkinson disease (PD), its long-term use is associated with the appearance of levodopa-induced dyskinesia (LID). Uric acid (UA) is believed to play an important neuroprotective role in PD. Objective To investigate if serum UA levels are related with the presence of LIDs in PD patients. Also, we investigated the associations among UA levels and clinical features of PD. Methods We enrolled 81 PD patients (dyskinesia = 48; no dyskinesia = 33) in the present study. A blood sample was collected to evaluate serum UA levels, clinical evaluation included the following instruments: Montreal Cognitive Assessment (MoCA), Beck Depression Inventory II (BDI-II), MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Hoehn and Yahr (HY), and the sub-item 4.1 of MDS-UPDRS IV (score ≥ 1). Additional relevant clinical information was obtained by a clinical questionnaire. Results Serum UA levels were lower in the dyskinesia group when compared with the no dyskinesia group. The same result was found in the UA levels of both men and women. The multivariate analysis showed lower uric acid levels were significantly associated with having dyskinesia (odds ratio [OR] = 0.424; 95% confidence interval [CI]: 0.221–0.746; p = 0.005). Additional analysis verified that serum UA levels are inversely correlated with depressive symptoms, disease duration, MDS-UPDRS IV and time spent with dyskinesia. A positive correlation was found with age at onset of PD symptoms. Conclusions The present study provides a possible role of serum UA levels in LID present in PD patients.